5 completed, 2 unknown. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 5, Unknown 2 |
Follow Next Generation Sequencing: new trials by email Literature Review of Next Generation Sequencing trials Research Report on Next Generation Sequencing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer Next Generation Sequencing, Biomarker Monitoring - Locally Advanced Carcinoma, Metastatic Cancer | Not applicable | Completed | Medical University of Graz | 235 | 2021-11-24 | 2026-09-01 |
| Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer next generation sequencing, following next generation sequencing - Genetic Change, Chemotherapy Effect | Not applicable | Unknown | Asan Medical Center | 10 | 2019-07-17 | 2022-07-20 |
| Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer Next generation sequencing - Gastrointestinal Cancer | Not applicable | Unknown | China Medical University, China | 50 | 2019-03-01 | 2019-04-16 |
| Utility of EUS-guided Microbiopsies in Pancreatic Cystic Lesions EUS-guided microbiopsy, Next Generation Sequencing - Pancreatic Cyst, IPMN | Not applicable | Completed | Herlev Hospital | 101 | 2018-02-01 | 2019-12-09 |
| DNA-mutation Analysis in Cyst Fluid of Suspected Intraductal Papillary Mucinous Neoplasia of the Pancreas Next Generation Sequencing, CEA and lipase, Cytology - Pancreas Cyst | Not applicable | Completed | Theresienkrankenhaus und St. Hedwig-Klinik GmbH | 150 | 2018-01-01 | 2022-12-20 |
| Clinical Utility of Pediatric Whole Exome Sequencing Whole Exome Sequencing - Encephalopathy, Birth Defect | Not applicable | Completed | University of California, San Francisco | 529 | 2017-08-01 | 2023-07-18 |
| Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS next generation sequencing, Fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET) - Non Hodgkin Lymphoma | Not applicable | Completed | Centre Henri Becquerel | 30 | 2014-11-01 | 2017-07-07 |
Pancreatic Cyst (2) · Abnormalities, Multiple (1) · Brain Diseases (1) · Cerebral Palsy (1) · Congenital Abnormalities (1) · Epilepsy (1) · Gastrointestinal Neoplasms (1) · Intellectual Disability (1) · Learning Disabilities (1) · Lymphoma, Non-Hodgkin (1) · Metabolic Diseases (1) · Mucocele (1) · Neoplasm Metastasis (1) · Neoplasm, Residual (1) · Pancreatic Neoplasms (1)
Asan Medical Center (1) · Centre Henri Becquerel (1) · China Medical University, China (1) · Herlev Hospital (1) · Medical University of Graz (1) · Theresienkrankenhaus und St. Hedwig-Klinik GmbH (1) · University of California, San Francisco (1)
Austria (1) · China (1) · Denmark (1) · France (1) · Germany (1) · South Korea (1) · United States (1)
Armin Gerger, Univ.Prof.,MD. (1) · Barbara Koenig, PhD (1) · Fabrice Jardin, Professor (1) · Mary Norton, MD (1) · Philipp Jost, Univ.Prof.Dr.MD, (1) · Pui-Yan Kwok, MD/PhD (1) · Song-Choel Kim, MD.PhD (1)
PMID 26883583, PMID 35396980, PMID 35964683
U01HG009599 (1)